Literature DB >> 22345971

Response: fospropofol: pharmacokinetics?

Girish M Bengalorkar1, K Bhuvana, N Sarala, Tn Kumar.   

Abstract

Entities:  

Year:  2012        PMID： 22345971      PMCID： PMC3275956          DOI： 10.4103/0970-9185.92473

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN： 0970-9185


× No keyword cloud information.
  5 in total

1.  Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation.

Authors:  Ajit Shah; Bipin Mistry; Ekaterina Gibiansky; Leonid Gibiansky
Journal:  Anesth Analg       Date:  2009-01       Impact factor: 5.108

2.  AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics.

Authors:  Ekaterina Gibiansky; Michel M R F Struys; Leonid Gibiansky; Ann L G Vanluchene; James Vornov; Eric P Mortier; Eric Burak; Luc Van Bortel
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

3.  Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion.

Authors:  Jörg Fechner; Harald Ihmsen; Dirk Hatterscheid; Christian Jeleazcov; Christine Schiessl; James J Vornov; Helmut Schwilden; Jürgen Schüttler
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

4.  Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats.

Authors:  M Schywalsky; H Ihmsen; A Tzabazis; J Fechner; E Burak; J Vornov; H Schwilden
Journal:  Eur J Anaesthesiol       Date:  2003-03       Impact factor: 4.330

5.  Fospropofol: clinical pharmacology.

Authors:  Girish M Bengalorkar; K Bhuvana; N Sarala; Tn Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.